Stock market announcement archive

LIFE: The European Patent Office issues a new Lifecare patent

March 21, 2024
Bergen, Norway, March 21st, 2024: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the European Patent Office (EPO) has notified that they will grant for a new patent to Lifecare. Reference is made to stock exchange notification November 8th, 2023, that EPO intended […]
Read more

LIFE: Poster presentations at ATTD 2024 in Firenze

March 6, 2024
Today starts the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024) in Firenze. Lifecare will be represented at the conference and have been accepted to present three poster presentations. ATTD is a leading international diabetes technology forum where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with […]
Read more

LIFE: Placing purchase order for cleanroom

March 5, 2024
Bergen, Norway, 5 March 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can disclose that Lifecare has placed the purchase order for a cleanroom. Reference is made to Lifecare’s list of trigger events, as presented at the semi-annual report of August 20th, 2023 and later […]
Read more

Lifecare Q4 2023 Report – Steady course

February 27, 2024
Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q4 financial report and operational update. Lifecare holds steady a course towards the upcoming automated pilot production. The first three quarters of 2023, Lifecare reported on huge achievements both […]
Read more

LIFE: Successful ISO 13485 audit

November 20, 2023
Bergen, Norway, November 20th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can disclose that Lifecare Laboratory (Mainz, Germany) has been successfully audited as part of the upcoming ISO 13485 certification. Reference is made to Lifecare’s list of trigger events, as presented at the […]
Read more